Explore Scholarly Literature Through PSOAR


Search Guidelines Through PGIAR

Wednesday, April 8, 2009

Free Access Databases for Pharmaceutical Research

The DrugBank database is a unique bioinformatics and cheminformatics resource that combines detailed drug (i.e. chemical, pharmacological and pharmaceutical) data with comprehensive drug target (i.e. sequence, structure, and pathway) information. The database contains nearly 4800 drug entries including >1,350 FDA-approved small molecule drugs, 123 FDA-approved biotech (protein/peptide) drugs, 71 nutraceuticals and >3,243 experimental drugs. Additionally, more than 2,500 non-redundant protein (i.e. drug target) sequences are linked to these FDA approved drug entries. Each DrugCard entry contains more than 100 data fields with half of the information being devoted to drug/chemical data and the other half devoted to drug target or protein data.

For more details visit http://www.drugbank.ca/


The service provides durg information information on solubility, permeability (LogP and clogP), permeability measured and BCS class which could be accessed by entering the drug name in search box or through therapeutic category option available on the website.

Visit http://www.tsrlinc.com/services/bcs/search.cfm# for more searching BCS related information for drugs.


bio syn said...

producing high quality peptide, custom peptide, amino acid analysis, bioconjugation and other related products and tools.

Mark Taylor said...

A leading life science products company which deals in Peptide, Custom Peptide, Peptide Synthesis, Custom Peptide Synthesis Services

prolab seo said...

This website is really a walk-through for all of the info you wanted about this and didn’t know who to ask. Glimpse here and you’ll definitely discover it. WONDERFUL Post! Thanks for sharing Free Access Databases for Pharmaceutical Research.. I will wait for more qualitative information Custom Peptide synthesis..

Alex cyril said...

This blog is really nice and helpful for readers to understanding better about the Custom peptide synthesis.